₹-0.04
(Market cap
₹5 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-4 Cr
-
ROE
-47.9 %
-
ROCE
-33.8 %
-
Industry P/E
--
-
EV/EBITDA
-15.9
-
Debt to Equity
0.3
-
Book Value
₹1.1
-
EPS
₹-0.7
-
Face value
2
-
Shares outstanding
55,562,000
10 Years Aggregate
CFO
₹-3.55 Cr
EBITDA
₹-7.67 Cr
Net Profit
₹-11.35 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zyden Gentec
| -17.1 | -8.4 | -13.0 | -20.2 | -50.5 | -21.9 | -26.0 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2015
|
2014
|
|---|---|---|
|
Zyden Gentec
| -27.5 | -56.8 |
|
BSE Sensex
| -5.0 | 29.9 |
|
BSE Healthcare
| 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zyden Gentec
|
0.9 | 4.8 | 1.2 | -3.8 | -- | -47.9 | -- | 0.4 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Zyden Gentec
Zyden Gentec Limited, a pharmaceutical company, manufactures and sells drug intermediates in India. It also designs, develops, patents, manufactures, and sells drugs, chemicals, and compounds. The company was incorporated in 1994 and is based in... Secunderabad, India. Read more
-
Incorporated
1994
-
Chairman
--
-
Managing Director
Vinod Shiv Kumar Gupta
-
Headquarters
Kota, Rajasthan
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zyden Gentec
What is the current share price of Zyden Gentec Ltd Today?
The share price of Zyden Gentec Ltd is ₹0.87 (BSE) as of 28-Mar-2016 IST. Zyden Gentec Ltd has given a return of -50.54% in the last 3 years.
What is the current PB & PE ratio of Zyden Gentec Ltd?
Since, TTM earnings of Zyden Gentec Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2019 |
0.00 |
0.00 |
2018 |
0.00 |
0.00 |
2017 |
0.00 |
0.00 |
2016 |
0.00 |
0.40 |
2015 |
0.00 |
0.48 |
What is the 52 Week High and Low of Zyden Gentec Ltd?
The 52-week high and low of Zyden Gentec Ltd are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of Zyden Gentec Ltd?
Zyden Gentec Ltd has a market capitalisation of ₹ 5 Cr as on 28-Mar-2016. As per SEBI classification, it is a company.
Should I invest in Zyden Gentec Ltd?
Before investing in Zyden Gentec Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.